Tigecycline resistance in clinical isolates of Enterococcus faecium is mediated by an upregulation of plasmid-encoded tetracycline determinants tet(L) and tet(M)

Journal of Antimicrobial Chemotherapy

Volumn 71, Issue 4, 2016, Pages 871-881

  Fiedler, S ^a   Bender, J K ^a   Klare, I ^a   Halbedel, S ^a   Grohmann, E ^b,c   Szewzyk, U ^d   Werner, G ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

^b BEUTH UNIVERSITY OF APPLIED SCIENCES   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d TECHNISCHE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; PENICILLIN DERIVATIVE; PROTEIN TET L; PROTEIN TET M; STREPTOMYCIN; TETRACYCLINE; TIGECYCLINE; TRANSCRIPTOME; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; MINOCYCLINE; TET M RESISTANCE PROTEIN, BACTERIA; TETL PROTEIN, ENTEROCOCCUS FAECALIS;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; ENTEROCOCCUS FAECIUM; GENE DOSAGE; LISTERIA MONOCYTOGENES; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLASMID; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; UPREGULATION; ANALOGS AND DERIVATIVES; DRUG EFFECTS; GENETICS; GRAM-NEGATIVE BACTERIAL INFECTIONS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BASE SEQUENCE; DRUG RESISTANCE, MICROBIAL; ENTEROCOCCUS FAECIUM; GENE DOSAGE; GRAM-NEGATIVE BACTERIAL INFECTIONS; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; PLASMIDS; POLYMERASE CHAIN REACTION; TETRACYCLINE RESISTANCE; UP-REGULATION;

EID: 84964318424     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkv420     Document Type: Article

References (45)

1. Cattoir V, Dowzicky MJ. A longitudinal assessment of antimicrobial susceptibility among important pathogens collected as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) in France between 2004 and 2012. Antimicrob Resist Infect Control 2014; 3: 36.
2. Sader HS, Farrell DJ, Flamm RK et al. Variation in potency and spectrum of tigecycline activity against bacterial strains from U.S. medical centers since its approval for clinical use (2006 to 2012). Antimicrob Agents Chemother 2014; 58: 2274-80.
3. Kresken M, Leitner E, Seifert H et al. Susceptibility of clinical isolates of frequently encountered bacterial species to tigecycline one year after the introduction of this new class of antibiotics: results of the second multicentre surveillance trial in Germany (G-TEST II, 2007). Eur J Clin Microbiol 2009; 28: 1007-11.
4. Deng M, Zhu MH, Li JJ et al. Molecular epidemiology and mechanisms of tigecycline resistance in clinical isolates of Acinetobacter baumannii from a Chinese university hospital. Antimicrob Agents Chemother 2014; 58: 297-303.
5. Moore IF, Hughes DW, Wright GD. Tigecycline is modified by the flavindependent monooxygenase TetX. Biochemistry 2005; 44: 11829-35.
6. Bartha NA, Soki J, Urban E et al. Investigation of the prevalence of tetQ, tetX and tetX1 genes in Bacteroides strains with elevated tigecycline minimum inhibitory concentrations. Int J Antimicrob Agents 2011; 38: 522-5.
7. He F, Fu Y, Chen Q et al. Tigecycline susceptibility and the role of efflux pumps in tigecycline resistance in KPC-producing Klebsiella pneumoniae. PLoS One 2015; 10: e0119064.
8. Zheng B, Li A, Jiang X et al. Genome sequencing and genomic characterization of a tigecycline-resistant Klebsiella pneumoniae strain isolated from the bile samples of a cholangiocarcinoma patient. Gut Pathog 2014; 6: 40.
9. Linkevicius M, Sandegren L, Andersson DI. Mechanisms and fitness costs of tigecycline resistance in Escherichia coli. J Antimicrob Chemother 2013; 68: 2809-19.
10. McAleese F, Petersen P, Ruzin A et al. A novelMATE family efflux pump contributes to the reduced susceptibility of laboratory-derived Staphylococcus aureus mutants to tigecycline. Antimicrob Agents Chemother 2005; 49: 1865-71.
11. Cattoir V, Isnard C, Cosquer T et al. Genomic analysis of reduced susceptibility to tigecycline in Enterococcus faecium. Antimicrob Agents Chemother 2015; 59: 239-44.
12. Bradford PA, Petersen PJ, YoungMet al. Tigecycline MIC testing by broth dilution requires use of fresh medium or addition of the biocatalytic oxygen-reducing reagent oxyrase to standardize the test method. Antimicrob Agents Chemother 2005; 49: 3903-9.
13. Leitner I, Nemeth J, Feurstein T et al. The third-generation P-glycoprotein inhibitor tariquidar may overcome bacterial multidrug resistance by increasing intracellular drug concentration. J Antimicrob Chemother 2011; 66: 834-9.
14. Marquez B. Bacterial efflux systems and efflux pumps inhibitors. Biochimie 2005; 87: 1137-47.
15. Kourtesi C, Ball AR, Huang YY et al. Microbial efflux systems and inhibitors: approaches to drug discovery and the challenge of clinical implementation. Open Microbiol J 2013; 7: 34-52.
16. Sudano Roccaro A, Blanco AR, Giuliano F et al. Epigallocatechin-gallate enhances the activity of tetracycline in staphylococci by inhibiting its efflux from bacterial cells. Antimicrob Agents Chemother 2004; 48: 1968-73.
17. German N, Kaatz GW, Kerns RJ. Synthesis and evaluation of PSSRI-based inhibitors of Staphylococcus aureus multidrug efflux pumps. Bioorg Med Chem Lett 2008; 18: 1368-73.
18. Ryu H, Henson M, Elk M et al. Development of quantitative PCR assays targeting the 16S rRNA genes of Enterococcus spp. and their application to the identification of Enterococcus species in environmental samples. Appl Environ Microbiol 2013; 79: 196-204.
19. Laverde Gomez JA, van Schaik W, Freitas AR et al. A multiresistance megaplasmid pLG1 bearing a hylEfm genomic island in hospital Enterococcus faecium isolates. Int J Med Microbiol 2011; 301: 165-75.
20. Werner G, Klare I, Heier H et al. Quinupristin/dalfopristin-resistant enterococci of the satA(vatD) and satG(vatE) genotypes from different ecological origins in Germany. Microb Drug Resist 2000; 6: 37-47.
21. Monk IR, Gahan CG, Hill C. Tools for functional postgenomic analysis of Listeria monocytogenes. Appl Environ Microb 2008; 74: 3921-34.
22. Chaillou S, Bor YC, Batt CA et al. Molecular cloning and functional expression in Lactobacillus plantarum 80 of xylT, encoding the D-xylose-H+ symporter of Lactobacillus brevis. Appl Environ Microbiol 1998; 64: 4720-8.
23. Song S, Park C. Utilization of D-ribose through D-xylose transporter. FEMS Microbiol Lett 1998; 163: 255-61.
24. Chopra I, Roberts M. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev 2001; 65: 232-60.
25. Schwarz S, Cardoso M, Wegener HC. Nucleotide sequence and phylogeny of the tet(L) tetracycline resistance determinant encoded by plasmid pSTE1 from Staphylococcus hyicus. Antimicrob Agents Chemother 1992; 36: 580-8.
26. Cook LC, Dunny GM. Effects of biofilm growth on plasmid copy number and expression of antibiotic resistance genes in Enterococcus faecalis. Antimicrob Agents Chemother 2013; 57: 1850-6.
27. Gibbons S. Phytochemicals for bacterial resistance-strengths, weaknesses and opportunities. Planta Med 2008; 74: 594-602.
28. German N, Wei P, Kaatz GW et al. Synthesis and evaluation of fluoroquinolone derivatives as substrate-based inhibitors of bacterial efflux pumps. Eur J Med Chem 2008; 43: 2453-63.
29. McMurry LM, Park BH, Burdett V et al. Energy-dependent efflux mediated by class L (tetL) tetracycline resistance determinant from streptococci. Antimicrob Agents Chemother 1987; 31: 1648-50.
30. Roberts MC. Update on acquired tetracycline resistance genes. FEMS Microbiol Lett 2005; 245: 195-203.
31. Bratu S, Landman D, George A et al. Correlation of the expression of acrB and the regulatory genes marA, soxS and ramA with antimicrobial resistance in clinical isolates of Klebsiella pneumoniae endemic to New York City. J Antimicrob Chemother 2009; 64: 278-83.
32. Sun JR, Chan MC, Chang TY et al. Overexpression of the adeB gene in clinical isolates of tigecycline-nonsusceptible Acinetobacter baumannii without insertion mutations in adeRS. Antimicrob Agents Chemother 2010; 54: 4934-8.
33. Dean CR, Visalli MA, Projan SJ et al. efflux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1. Antimicrob Agents Chemother 2003; 47: 972-8.
34. Qin X, Galloway-Pena JR, Sillanpaa J et al. Complete genome sequence of Enterococcus faecium strain TX16 and comparative genomic analysis of Enterococcus faecium genomes. BMC Microbiol 2012; 12: 135.
35. Boerlin P. Molecular epidemiology and genetic linkage of macrolide and aminoglycoside resistance in Staphylococcus intermedius of canine origin. Vet Microbiol 2001; 79: 155-69.
36. Werner G, Hildebrandt B, WitteW. Aminoglycoside-streptothricin resistance gene cluster aadE-sat4-aphA-3 disseminated among multiresistant isolates of Enterococcus faecium. Antimicrob Agents Chemother 2001; 45: 3267-9.
37. Jensen LB, Garcia-Migura L, Valenzuela AJ et al. A classification system for plasmids fromenterococci and other Gram-positive bacteria. J Microbiol Methods 2010; 80: 25-43.
38. Mileyko Y, Joh RI, Weitz JS. Small-scale copy number variation and largescale changes in gene expression. ProcNatl Acad Sci USA 2008; 105: 16659-64.
39. Olson MW, Ruzin A, Feyfant E et al. Functional, biophysical, and structural bases for antibacterial activity of tigecycline. Antimicrob Agents Chemother 2006; 50: 2156-66.
40. Rasmussen BA, Gluzman Y, Tally FP. Inhibition of protein synthesis occurring on tetracycline-resistant, TetM-protected ribosomes by a novel class of tetracyclines, the glycylcyclines. Antimicrob Agents Chemother 1994; 38: 1658-60.
41. Niebel M, Quick J, Prieto AMG et al. Deletions in a ribosomal proteincoding gene are associated with tigecycline resistance in Enterococcus faecium. Int J Antimicrob Agents 2015; 46: 572-5.
42. Hu M, Nandi S, Davies C et al. High-level chromosomally mediated tetracycline resistance in Neisseria gonorrhoeae results from a point mutation in the rpsJ gene encoding ribosomal protein S10 in combination with the mtrR and penB resistance determinants. Antimicrob Agents Chemother 2005; 49: 4327-34.
43. Schleifer KH, Kilpper-Balz R. Transfer of Streptococcus faecalis and Streptococcus faecium to the genus Enterococcus nom. rev. as Enterococcus faecalis comb. nov. and Enterococcus faecium comb. nov. Int J Syst Bacteriol 1984; 34: 31-4.
44. Werner G, Gfrorer S, Fleige C et al. Tigecycline-resistant Enterococcus faecalis strain isolated from a German intensive care unit patient. Antimicrob Agents Chemother 2008; 61: 1182-3.
45. Glaser P, Frangeul L, Buchrieser C et al. Comparative genomics of Listeria species. Science 2001; 294: 849-52.